ESTABLISHMENT LABS HLDGS
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force… Read more
ESTABLISHMENT LABS HLDGS (3E0) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ESTABLISHMENT LABS HLDGS (3E0) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ESTABLISHMENT LABS HLDGS - Net Assets Trend (None–None)
This chart illustrates how ESTABLISHMENT LABS HLDGS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ESTABLISHMENT LABS HLDGS (None–None)
The table below shows the annual net assets of ESTABLISHMENT LABS HLDGS from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ESTABLISHMENT LABS HLDGS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ESTABLISHMENT LABS HLDGS Competitors by Market Cap
The table below lists competitors of ESTABLISHMENT LABS HLDGS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Suzhou Shijia Science & Technology Inc
SHE:002796
|
$1.08 Billion |
|
Spartan Resources Limited
PINK:GYYSF
|
$1.08 Billion |
|
Lanzhou LS Heavy Equipment Co
SHG:603169
|
$1.08 Billion |
|
U-BLOX N .LINIE AG
SW:UBXNE
|
$1.08 Billion |
|
Shenzhen Agricultural Products Co Ltd
SHE:000061
|
$1.08 Billion |
|
Nagase & Company Ltd
OTCMKTS:NGSCF
|
$1.08 Billion |
|
Oesterr. Post AG
VI:POST
|
$1.08 Billion |
|
THANACHART CAP.-FGN-BA 10
F:NFPH
|
$1.08 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ESTABLISHMENT LABS HLDGS's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ESTABLISHMENT LABS HLDGS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ESTABLISHMENT LABS HLDGS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ESTABLISHMENT LABS HLDGS's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ESTABLISHMENT LABS HLDGS (3E0) | €- | N/A | N/A | $1.08 Billion |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |